Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow processing for transplantation.

E M Areman1, R A Sacher

  • 1Department of Laboratory Medicine, Georgetown University Medical Center, Washington, DC 20007.

Transfusion Medicine Reviews
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.

Neurology·2009
Same author

Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.

Neurology·2003
Same author

Evidence-based recommendations for the use of WBC-reduced cellular blood components.

Transfusion·2001
Same author

Intravenous immunoglobulin consensus statement.

The Journal of allergy and clinical immunology·2001
Same author

Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs.

Journal of hematotherapy & stem cell research·2000
Same author

RBC T activation and hemolysis: implications for pediatric transfusion management.

Transfusion·2000
Same journal

Assessment of CTLA-4, LAG-3, and TIM-3 Expression in Pediatric Patients With β-Thalassemia Major and Their Association With Alloimmunization.

Transfusion medicine reviews·2026
Same journal

A Reply to "Beyond Implementation: The Need for Validation, Equity, and Real-World Accountability in AI for Transfusion Medicine".

Transfusion medicine reviews·2026
Same journal

Beyond Implementation: The Need for Validation, Equity, and Real-World Accountability in AI for Transfusion Medicine.

Transfusion medicine reviews·2026
Same journal

Trust Over Knowledge: Rethinking Donor Iron Supplementation Strategies in Modern Blood Services-Authors' reply.

Transfusion medicine reviews·2026
Same journal

The Effect of Stress Ball and Music on Anxiety, Distress, and Pain Levels During Platelet Apheresis Donation: Randomized Controlled Trial.

Transfusion medicine reviews·2026
Same journal

Therapeutic Plateletpheresis for Thrombocytosis: Critical Analytic Reviews and Original Multicenter Experience.

Transfusion medicine reviews·2026
See all related articles

Bone marrow processing for transplantation (BMT) varies widely, impacting engraftment and disease outcomes. Establishing flexible standards for bone marrow processing is crucial for quality control and patient survival.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Cellular Therapy

Background:

  • Bone marrow transplantation (BMT) indications are increasing, leading to diverse processing techniques.
  • Current methods for mononuclear cell purification, concentration, and storage vary significantly between centers.
  • Autologous BMT for malignant disease involves unique procedures to maximize cell yields and reduce graft-versus-host (GVH) disease.

Purpose of the Study:

  • To highlight the variability in bone marrow processing techniques.
  • To discuss the challenges and limitations of current manipulated marrow procedures.
  • To advocate for the integration of transfusion medicine principles into bone marrow processing.

Main Methods:

  • Review of current bone marrow processing and manipulation techniques.

Related Experiment Videos

  • Discussion of challenges in optimizing cell yields, engraftment, and GVH disease prevention.
  • Exploration of innovative purging techniques and quality control measures.

    • Main Results:

    • Graft rejection and disease relapse remain issues with manipulated marrows.
    • Titration of immune reconstituting cells is imprecise, potentially compromising disease-free survival.
    • Lack of established standards for bone marrow processing necessitates flexible yet practical criteria.

    Conclusions:

    • Flexible standards are needed for bone marrow processing, incorporating quality control and viability assays.
    • Transfusion medicine best practices should be integrated into bone marrow processing.
    • Standardization can improve the quality and efficacy of processed bone marrow for transplantation.